Xspray-logo-white
  • Home
  • About us
    • Business model
    • Our history – a timeline
    • Board of Directors & Board committees
    • Management
  • Technology
  • Pipeline
  • Media
  • Contact
  • Investors
  • en en
    • sv sv
  • Investors
    • Share information
      • Ownership structure
    • Financial calendar & Events
    • Financial reports
      • ESEF report
    • Prospectus
    • Press releases
    • Corporate governance
      • Corporate Structure
      • General meetings
      • Corporate Governance Reports
      • Nomination committee
      • Board of Directors & Board committees
      • Management
      • Accounting principles
      • Internal control & Risk management
      • Auditor
      • Articles of association
      • Remuneration
    • Rights Issue 2025

Press releases

All press releases Regulatory

Press release 2020-05-14

Xspray Pharma publishes Interim report Q1, January – March 2020

Regulatory press release 2020-04-15

Xspray Pharma provides an update on how the Covid-19 pandemic affects the company’s planned clinical studies

Regulatory press release 2020-04-14

XSpray: Notice of annual general meeting of Xspray Pharma AB (publ)

Press release 2020-03-27

Trading in Xspray Pharma’s shares commences today on Nasdaq Stockholm

Press release 2020-03-26

Bulletin from the extraordinary general meeting of Xspray Pharma AB (publ)

Press release 2020-03-26

The conditions for Xspray Pharma’s listing on Nasdaq Stockholm have been fulfilled

Press release 2020-03-23

Xspray Pharma publishes prospectus in connection with its listing on Nasdaq Stockholm

Regulatory press release 2020-03-18

Xspray Pharma approved for listing on Nasdaq Stockholm

Regulatory press release 2020-03-17

Xspray receives notification of manufacturing approval and provides update on clinical studies

Press release 2020-02-28

Xspray Pharma publishes Interim report Q4, January – December 2019

Show more

IR contact

Jacob Nyberg, IRO

+46 (0)70 767 08 83

info@xspray.com

Subscribe

  • Submit to our press releases and get an email every time we publish a press release or report on our website.
  • When clicked on Send I agree that my personal information will be saved. Read more
  • This field is for validation purposes and should be left unchanged.
Xspray-logo-white

Xspray Pharma AB Scheeles väg 2 171 65 Solna

+46 (0)8 730 37 00 info@xspraypharma.com

We use cookie to give you the best experience of our site. If you continue to use this website we will assume you agree. Read more about our Privacy policy.I agree